| RS2493824378 |
DCHS1
|
Health Risk |
Pathogenic |
— |
| RS2493825774 |
CTSD
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2493825798 |
CTSD
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2493830143 |
CTSD
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2493831760 |
DCHS1
|
Health Risk |
Pathogenic |
— |
| RS2493834457 |
CTSD
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2493834507 |
CTSD
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2493836772 |
DENND5A
|
Health Risk |
Likely pathogenic |
— |
| RS2493839816 |
DCHS1
|
Health Risk |
Pathogenic |
— |
| RS2493841471 |
HACD1
|
Health Risk |
Pathogenic |
Congenital myopathy 11, Congenital myopathy 11 |
| RS2493842342 |
ECHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2493842376 |
ECHS1
|
Health Risk |
Likely pathogenic |
— |
| RS2493842433 |
ECHS1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2493843791 |
DCHS1
|
Health Risk |
Pathogenic |
Van Maldergem syndrome 1, Van Maldergem syndrome 1 |
| RS2493847217 |
HPSE2
|
Health Risk |
Likely pathogenic |
— |
| RS2493847739 |
ECHS1
|
Health Risk |
Likely pathogenic |
Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency, Mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency |
| RS2493849055 |
HACD1
|
Health Risk |
Pathogenic |
— |
| RS2493850822 |
MPDZ
|
Health Risk |
Pathogenic |
— |
| RS2493852190 |
FBN1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2493859114 |
HACD1
|
Health Risk |
Pathogenic |
— |
| RS2493868037 |
HACD1
|
Health Risk |
Likely pathogenic |
Congenital myopathy 11, Congenital myopathy 11 |
| RS2493869193 |
HACD1
|
Health Risk |
Pathogenic |
Congenital myopathy 11, Congenital myopathy 11 |
| RS2493870342 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2493870388 |
KCNQ1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiac arrhythmia, Long QT syndrome |
| RS2493870444 |
KCNQ1
|
Health Risk |
Likely pathogenic |
Long QT syndrome 1, Long QT syndrome 1 |
| RS2493874595 |
DENND5A
|
Health Risk |
Pathogenic |
— |
| RS2493876974 |
COPB1
|
Health Risk |
Pathogenic |
Short stature, Failure to thrive |
| RS2493890591 |
SFXN4
|
Health Risk |
Pathogenic |
— |
| RS2493902455 |
HACD1
|
Health Risk |
Pathogenic |
— |
| RS2493906863 |
DENND5A
|
Health Risk |
Pathogenic |
— |
| RS2493908435 |
MYO3A
|
Health Risk |
Likely pathogenic |
MYO3A-related disorder, MYO3A-related disorder |
| RS2493910357 |
MYO3A
|
Health Risk |
Pathogenic |
— |
| RS2493914688 |
WHRN
|
Health Risk |
Pathogenic |
— |
| RS2493926592 |
MYO3A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 30, Autosomal recessive nonsyndromic hearing loss 30 |
| RS2493927502 |
DNA2
|
Health Risk |
Pathogenic |
Seckel syndrome 8, Seckel syndrome 8 |
| RS2493938011 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS2493938246 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2493938342 |
CDH23
|
Health Risk |
Pathogenic |
Usher syndrome, Usher syndrome |
| RS2493939214 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS2493944670 |
CEP55
|
Health Risk |
Likely pathogenic |
Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome, Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome |
| RS2493945713 |
SHOC2
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, RASopathy |
| RS2493948073 |
HPS5
|
Health Risk |
Pathogenic |
— |
| RS2493949477 |
PCDH15
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2493949917 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2493950607 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2493951813 |
RRAS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Adenocarcinoma of the large intestine, Noonan syndrome 12 |
| RS2493953727 |
SYNE1
|
Health Risk |
Likely pathogenic |
— |
| RS2493954647 |
SOX6
|
Health Risk |
Likely pathogenic |
Tolchin-Le Caignec syndrome, Tolchin-Le Caignec syndrome |
| RS2493960489 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS2493960548 |
CDH23
|
Health Risk |
Likely pathogenic |
Usher syndrome, Usher syndrome |
| RS2493960610 |
CDH23
|
Health Risk |
Pathogenic |
Usher syndrome, Usher syndrome |
| RS2493960671 |
CDH23
|
Health Risk |
Pathogenic/Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS2493961036 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS2493961296 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2493964760 |
PRDX3
|
Health Risk |
Likely pathogenic |
— |
| RS2493967150 |
TNNI2
|
Health Risk |
Likely pathogenic |
Distal arthrogryposis type 2B1, Distal arthrogryposis type 2B1 |
| RS2493967214 |
TNNI2
|
Health Risk |
Likely pathogenic |
Distal arthrogryposis type 2B1, Distal arthrogryposis type 2B1 |
| RS2493971978 |
SOX6
|
Health Risk |
Pathogenic |
Tolchin-Le Caignec syndrome, Tolchin-Le Caignec syndrome |
| RS2493973819 |
PRDX3
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia, autosomal recessive 32 |
| RS2493978793 |
SOX6
|
Health Risk |
Likely pathogenic |
— |
| RS2493979514 |
BAG3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Myofibrillar myopathy 6 |
| RS2493979552 |
BAG3
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS2493979814 |
BAG3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS2493980073 |
BAG3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2493980111 |
BAG3
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS2493980114 |
BAG3
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS2493980164 |
BAG3
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS2493980818 |
EBF3
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2493981548 |
EBF3
|
Health Risk |
Likely pathogenic |
Hypotonia, ataxia |
| RS2493988502 |
HPS5
|
Health Risk |
Pathogenic |
— |
| RS2493999571 |
DNA2
|
Health Risk |
Pathogenic |
Rothmund-Thomson syndrome, Rothmund-Thomson syndrome type 4 |
| RS2494001262 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS2494001370 |
CDH23
|
Health Risk |
Likely pathogenic |
— |
| RS2494007936 |
DNHD1
|
Health Risk |
Pathogenic |
— |
| RS2494009026 |
BAG3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2494009217 |
BAG3
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS2494009473 |
BAG3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS2494009499 |
BAG3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS2494009610 |
BAG3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Myofibrillar myopathy 6 |
| RS2494009703 |
BAG3
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS2494009711 |
BAG3
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1HH, Dilated cardiomyopathy 1HH |
| RS2494009723 |
BAG3
|
Health Risk |
Pathogenic |
— |
| RS2494009726 |
BAG3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS2494009729 |
BAG3
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS2494009825 |
BAG3
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS2494013310 |
BAG3
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |
| RS2494014139 |
BAG3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS2494014239 |
BAG3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Primary familial dilated cardiomyopathy |
| RS2494014414 |
BAG3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS2494014941 |
BAG3
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1HH, Dilated cardiomyopathy 1HH |
| RS2494016040 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2494019349 |
DNA2
|
Health Risk |
Likely pathogenic |
Rothmund-Thomson syndrome, Rothmund-Thomson syndrome type 4 |
| RS2494021553 |
CDH23
|
Health Risk |
Likely pathogenic |
— |
| RS2494021576 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS2494021726 |
CDH23
|
Health Risk |
Pathogenic |
Usher syndrome type 1, Usher syndrome type 1 |
| RS2494022006 |
CDH23
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2494022078 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2494022190 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS2494022472 |
BAG3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1HH |
| RS2494022514 |
BAG3
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1HH, Myofibrillar myopathy 6 |